Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease
Related Experiment Video
Updated: Dec 10, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
1Departments of Epidemiology and Cardiology, Erasmus MC-University Medical Center Rotterdam, The Netherlands. Department of Clinical Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.
No abstract available in PubMed .
More Related Videos
04:30A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease V: Interprofessional Care
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...